10x Genomics & SPT Labtech: Automation Boost

10x Genomics stock saw a slight bump after announcing a partnership with SPT Labtech to automate single-cell research, making lab work faster and more consistent. This deal, building on previous connections, aims to streamline experiments, but broader market concerns about US-China trade tensions and past stock volatility continue to overshadow the positive news, leaving the stock still down 15% year-to-date.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.